Gefitinib Tablet 250 mg Tyrogef

Trade Name: Tyrogef

Manufacturer: Sun Pharmaceutical Industries Ltd

Presentation: Tablet

Strength: 250mg

Common side effects of Gefitinib Tablet 250 mg Tyrogef include:

One of the most noticeable side effects of Gefitinib Tablet 250 mg is squeamishness, followed by a rash, vomiting, and weight loss. In case it bothers you, drinks plenty of fluids or sees your health care physician. Because it makes you more susceptible to the sun, you should wear protective clothing or apply sunscreen when going outside. Any ulceration in your mouth, changes in your eyesight, or breathing difficulties should be communicated to the subject matter expert as soon as they occur. While you are taking this medication, your primary care physician may provide you with the customary warning about liver limitations. For more click here.

Gefitinib Tablet 250 mg Tyrogef is what it is:

It is prescribed for the treatment of non-little cell breakdown in the lungs using gefitinib tablet 250 mg. In individuals with cancer that has spread to numerous parts of the body, who have unusual epidermal advancement factor receptor (EGFR) characteristics, and who have not previously received treatment for the illness, it is utilized to treat them.

Gefitinib tablet 250 mg is used in what way?

As long as your important consideration doctor advises you to do so, you should keep it on your radar screen. The length of your treatment is determined by your individual needs and reaction to treatment. You should consider it definitively as your most important consideration, as suggested by your doctor. When it is mistaken for anything else or when it is taken in excess, it might have major unexpected consequences. It may take a few weeks or months before you notice or feel the advantages, but don’t stop taking it until your primary care physician (PCP) advises you to do so.

How much does gefitinib cost?

During this investigation, it was discovered that the revised ICER for gefitinib was estimated to be in the upper range of $45,000-$75,000/QALY. In order to ensure consistency with the training undertaken by Public Summary Documents, the incremental expense adequacy proportions have been presented as a means of reaching out.

What is the difference between erlotinib and gefitinib?

While gefitinib has been approved solely for the treatment of patients with EGFR transformation, regardless of the line of treatment they have had, erlotinib has also been found to be effective in patients who do not have an EGFR mutation but who have received second- or third-line treatment.

Why was gefitinib withdrawn?

AstraZeneca voluntarily withdrew IRESSA (gefitinib) Tablets from the market on August 26, 2010, according to the Food and Drug Administration (FDA), because the postmarketing studies needed as a condition of approval under Subpart H failed to check and confirm clinical benefit.

Assuming that you are searching for another item or brand click here.